Total Voting Rights (61)

Total Voting Rights

RNS Number : 8358R
CVC Credit Partners European Opps.
31 October 2019
 

31 October 2019

 

CVC Credit Partners European Opportunities Limited

(a closed-ended investment company incorporated in Jersey with registration number 112635)
Registered Office: IFC 1, The Esplanade, St Helier, Jersey, JE1 4BP

 

Total Voting Rights

 

Further to the completion of the October 2019 share conversion today and pursuant to Rule 5.6.1 of the FCA's Disclosure Guidance and Transparency Rules, CVC Credit Partners European Opportunities Limited ("the Company") notifies the market of the following:

 

As at 9am on 31 October 2019, the Company's issued share capital (excluding treasury shares) consisted of:

 

132,332,311 ordinary Euro shares of no par value

351,451,599 ordinary Sterling shares of no par value

 

Each ordinary Euro share carries the right to 1 vote and each ordinary Sterling share carries the right to 1.17 votes.

 

The total number of voting rights of the ordinary Euro shares of no par value is 132,332,311 and of the ordinary Sterling shares of no par value is 411,198,370. The total number of voting rights in the Company is 543,530,681. The Company will hold the following ordinary shares in treasury:

 

4,703,590 ordinary Euro shares of no par value (non-voting)

25,357,791 ordinary Sterling shares of no par value (non-voting)

 

The above figure (543,530,681) may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in or a change to their interest in the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

CVC Credit Partners European Opportunities Limited: +44 (0)1534 625522
Richard Boléat

BNP Paribas Securities Services S.C.A., Jersey Branch           +44 (0)1534 709181/813820

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TVRWGGGWUUPBGCG